Guest guest Posted February 2, 2005 Report Share Posted February 2, 2005 I wanted to post the following since the topic came up about it last week and I decided to do some research on it. This is from the MDA website: SUBJ (11/02): DECREASING RISK OF OSTEOPOROSIS I am a 59-year-old female diagnosed with Charcot-Marie-Tooth disease (CMT). With the recent news about the lack of benefit and risks of hormone replacement therapy (HRT), I have concerns about the prevalence of osteoporosis for women with CMT. My mother who had CMT had severe osteoporosis and I understand that women with CMT are more prone to osteoporosis. That was one of the reasons several years ago that I decided to take the hormone replacement therapy. Now my gynecologist is recommending that I stop HRT. I wonder if you are aware of any research on other available products that might lower the risk of osteoporosis in women with CMT? REPLY [1] from MDA: Stanley B. Holstein, M.D., MDA Clinic Director, New Rochelle, NY There are reports of neuropathy associated with osteoporosis. Diabetic neuropathy resulted in a 12 percent reduction in bone mineral density of the distal limb of patients (Diabetic Medicine 1995, 12:874). Another report showed osteoporosis of the metaphysial line of the bones of the foot (ls Medicine Interne 1979, 130:219). Although these studies refer to diabetic neuropathy, it is possible to relate osteoporosis to the neuropathy of Charcot-Marie-Tooth disease (CMT) as well. Possible mechanisms may include reduced activity and weight bearing or neuropathic trophic factors that may be needed for bone mineralization. In any case, other treatment options include the biophosphonate alandronate (Fosomax) or raloxifene (Evista) as stated in the recent article in JAMA 2002, 288:100 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.